{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T05:03:37Z","timestamp":1779771817579,"version":"3.53.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005831","name":"Foundation for Anesthesia Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005831","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bja.2025.09.011","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T20:11:58Z","timestamp":1761250318000},"page":"1595-1597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["More than analgesia: evidence for metabolic regulation by the kappa opioid receptor in triple-negative breast cancer"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7596-9401","authenticated-orcid":false,"given":"Joseph R.","family":"Scarpa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2482-3154","authenticated-orcid":false,"given":"Joshua S.","family":"Mincer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2025.09.011_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bja.2019.04.062","article-title":"Influence of perioperative anaesthetic and analgesic interventions on oncological outcomes: a narrative review","volume":"123","author":"Wall","year":"2019","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.09.011_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fanes.2024.1464004","article-title":"Towards a precision approach to anesthetic\/analgesic immunomodulation in cancer","volume":"3","author":"Gupta","year":"2024","journal-title":"Front Anesthesiol"},{"key":"10.1016\/j.bja.2025.09.011_bib3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4049\/immunohorizons.2000019","article-title":"Transcriptomic analysis reveals receptor subclass\u2013specific immune regulation of CD8+ T cells by opioids","volume":"4","author":"Mazahery","year":"2020","journal-title":"Immunohorizons"},{"key":"10.1016\/j.bja.2025.09.011_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1267532","article-title":"Opioids and immune checkpoint inhibitors differentially regulate a common immune network in triple-negative breast cancer","volume":"13","author":"Scarpa","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.bja.2025.09.011_bib5","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bja.2025.09.011_bib6","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ccell.2018.03.014","article-title":"A comprehensive pan-cancer molecular study of gynecologic and breast cancers","volume":"33","author":"Berger","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bja.2025.09.011_bib7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","author":"Bass","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bja.2025.09.011_bib8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3389\/fphys.2018.00399","article-title":"Identification of biomarkers associated with pathological stage and prognosis of clear cell renal cell carcinoma by co-expression network analysis","volume":"9","author":"Chen","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.bja.2025.09.011_bib9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1213\/ANE.0000000000003428","article-title":"Effects of intraoperative opioid use on recurrence-free and overall survival in patients with esophageal adenocarcinoma and squamous cell carcinoma","volume":"127","author":"Du","year":"2018","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2025.09.011_bib10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bja.2022.04.024","article-title":"Intraoperative opioids are associated with decreased recurrence rates in colon adenocarcinoma: a retrospective observational cohort study","volume":"129","author":"Yuval","year":"2022","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.09.011_bib11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bja.2021.03.030","article-title":"Intraoperative opioid exposure, tumour genomic alterations, and survival differences in people with lung adenocarcinoma","volume":"127","author":"Connolly","year":"2021","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.09.011_bib12","doi-asserted-by":"crossref","first-page":"e402","DOI":"10.1016\/j.bja.2020.06.036","article-title":"Impact of intraoperative opioid and adjunct analgesic use on renal cell carcinoma recurrence: role for onco-anaesthesia","volume":"125","author":"Silagy","year":"2020","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.09.011_bib13","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1158\/0008-5472.CAN-20-1852","article-title":"Identifying clear cell renal cell carcinoma coexpression networks associated with opioid signaling and survival","volume":"81","author":"Scarpa","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.bja.2025.09.011_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.801411","article-title":"Solid tumour opioid receptor expression and oncologic outcomes: analysis of the Cancer Genome Atlas and Genotype Tissue Expression Project","volume":"12","author":"Belltall","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.bja.2025.09.011_bib15","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.3390\/curroncol31060235","article-title":"Opioids and cancer: current understanding and clinical considerations","volume":"31","author":"Sah","year":"2024","journal-title":"Curr Oncol"},{"key":"10.1016\/j.bja.2025.09.011_bib16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/anae.16464","article-title":"The effect of the type of anaesthesia on long-term outcomes after cancer resection surgery: a narrative review","volume":"80","author":"Bezu","year":"2025","journal-title":"Anaesthesia"},{"key":"10.1016\/j.bja.2025.09.011_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bjao.2022.100010","article-title":"Opioids and cancer survival: are we looking in the wrong place?","volume":"2","author":"Giakomidi","year":"2022","journal-title":"BJA Open"},{"key":"10.1016\/j.bja.2025.09.011_bib18","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.bja.2024.09.031","article-title":"Kappa opioid receptor internalisation-induced p38 nuclear translocation suppresses glioma progression","volume":"134","author":"Li","year":"2025","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.09.011_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115462","article-title":"Activation of kappa opioid receptor (KOR) inhibits estrogen receptor (ER)-positive breast cancer through the KOR-ER-XBP1 pathway","volume":"167","author":"Shi","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bja.2025.09.011_bib20","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.bja.2025.07.093","article-title":"\u03ba-Opioid receptor activation suppresses triple-negative breast cancer progression by inducing urea cycle dysfunction and mitochondrial damage in vitro and in mice","volume":"135","author":"Shi","year":"2025","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.09.011_bib21","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.bja.2024.10.014","article-title":"Targeting the kappa opioid receptor for analgesia and antitumour effects","volume":"134","author":"Lambert","year":"2025","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.09.011_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1143798","article-title":"Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer","volume":"13","author":"Ni","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.bja.2025.09.011_bib23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","article-title":"Glutamine addiction: a new therapeutic target in cancer","volume":"35","author":"Wise","year":"2010","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.bja.2025.09.011_bib24","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1126\/science.aam9305","article-title":"Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass","volume":"358","author":"Spinelli","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bja.2025.09.011_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107241","article-title":"Kappa opioid receptor activation increases thermogenic energy expenditure which drives increased feeding","volume":"26","author":"Cone","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.bja.2025.09.011_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.837671","article-title":"The kappa opioid receptor: a promising therapeutic target for multiple pathologies","volume":"13","author":"Dalefield","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bja.2025.09.011_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bja.2023.02.001","article-title":"Anaesthesia, analgesia, and cancer outcomes: time to think like oncologists?","volume":"131","author":"Mincer","year":"2023","journal-title":"Br J Anaesth"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091225006440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091225006440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T04:24:07Z","timestamp":1779769447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091225006440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0007091225006440"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2025.09.011","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"More than analgesia: evidence for metabolic regulation by the kappa opioid receptor in triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2025.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2025.07.093","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}